EirGenix (TPE:6589) Accounts Payable: NT$100 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$46.25
GF Value NT$93.18
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix Accounts Payable?

EirGenix TPE:6589 -2.22% 58 Accounts Payable is NT$100 Mil as of Dec. 2025. GuruFocus rates TPE:6589 with a GF Score™ of 58/100 and a GF Value™ of NT$93.18 (Possible Value Trap). The stock has 6 warning signs investors should review.

EirGenix's Accounts Payable for the quarter that ended in Dec. 2025 was NT$100 Mil.

EirGenix's quarterly Accounts Payable declined from Jun. 2025 (NT$77 Mil) to Sep. 2025 (NT$53 Mil) but then increased from Sep. 2025 (NT$53 Mil) to Dec. 2025 (NT$100 Mil).

EirGenix's annual Accounts Payable increased from Dec. 2023 (NT$80 Mil) to Dec. 2024 (NT$87 Mil) and increased from Dec. 2024 (NT$87 Mil) to Dec. 2025 (NT$100 Mil).

EirGenix Accounts Payable Historical Data

* Premium members only.

The historical data trend for EirGenix's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EirGenix Accounts Payable Chart

EirGenix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.46 134.61 79.56 87.29 99.86

EirGenix Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.29 96.43 76.65 52.75 99.86
TPE:6589
58GF Score
EirGenix Inc TPE:6589
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EirGenix Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$100 Mil mean?
EirGenix (TPE:6589) has a Accounts Payable of NT$100 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EirGenix and its competitors.
Is EirGenix's Accounts Payable too high?
EirGenix's current Accounts Payable is NT$100 Mil. Overall, EirGenix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EirGenix's Accounts Payable compare to VRTX and REGN?
EirGenix's Accounts Payable of NT$100 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on EirGenix and its competitors. EirGenix's current Accounts Payable is NT$100 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EirGenix stock overvalued right now?
Based on GuruFocus' analysis, EirGenix (TPE:6589) is currently considered Possible Value Trap. The stock's GF Value™ is NT$93.18, compared to a current price of NT$46.25 — trading 50.4% below its estimated fair value. The current Accounts Payable is NT$100 Mil. EirGenix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For EirGenix (TPE:6589), the current Accounts Payable is NT$100 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$46.25 is trading 50.4% below its estimated GF Value™ of NT$93.18. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • Accounts Payable: NT$100 Mil
  • GF Value™: NT$93.18 vs. price of NT$46.25 (50.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.25
Price
NT$93.18
GF Value